GLP-1 Medication Guides
Evidence-based guides covering everything you need to know about GLP-1 weight loss medications, from how they work to choosing a provider.
Best GLP-1 Providers 2026: Price, Quality, Access Rankings
Our definitive 2026 ranking of the best GLP-1 providers by price, quality, and access. Compare top online semaglutide and tirzepatide options for effective
Investigating GLP-1 in Alzheimer's: Emerging Research
Discover how GLP-1 analogues, traditionally for metabolic health, are showing promise in Alzheimer's disease research. We examine their neuroprotective
GLP-1s for Pediatric Obesity: Wegovy's Approval and Emerging Data
Semaglutide (Wegovy) and liraglutide (Saxenda) are FDA-approved GLP-1s for adolescent obesity. We examine clinical trial data, safety, and future directions.
Hims GLP-1 Program Review: Cost, Medications, and Patient Experience
Hims GLP-1 Program: A deep dive into cost, medication options, prescriber quality, and patient outcomes. Evaluate if Hims offers a credible path for weight
Tmates Tirzepatide Review: Is It the Cheapest Online?
GLP-1 Source reviews Tmates' tirzepatide program, examining its pricing, compounded quality, and included services. We compare Tmates against brand-name
G-Plans GLP-1 Review 2026: Is Personalized Weight Loss Worth It?
G-Plans combines GLP-1 medication with personalized nutrition plans. We review their approach, pricing, and efficacy for weight loss in 2026.
GLP-1 Drugs and Addiction: A New Frontier in Substance Use Treatment
Emerging research shows GLP-1 medications may reduce addictive behaviors, with one study reporting a 51% lower risk of alcohol use disorder in veterans.
GLP-1s: Beyond Weight, Directly Lowering Blood Pressure
GLP-1 receptor agonists lower blood pressure through both indirect weight-loss mechanisms and direct cardiovascular effects, reducing hypertension risk.
GLP-1 Medications: A New Frontier in Treating Binge Eating Disorder
GLP-1 drugs like semaglutide show promise in managing Binge Eating Disorder by reducing cravings and food preoccupation, offering a novel therapeutic
How to Get Wegovy at a Discount in 2026: What Actually Works
Navigating Wegovy costs in 2026 is crucial. Discover manufacturer savings cards, new telehealth discounts, and specific programs that provide genuine
Tmates Semaglutide Review 2026: An Affordable Telehealth Option
Review Tmates' compounded semaglutide program, evaluating pricing, quality, and how it compares to platforms like RemedyMeds and Ro. Tmates aims for
GLP-1 Agonists: A New Frontier in Kidney Protection
Exploring the burgeoning evidence of GLP-1 receptor agonists in safeguarding kidney health, beyond glycemic control, offering new hope for CKD patients.
GLP-1 Agonists: Revolutionizing Lipid Management
Discover how GLP-1 receptor agonists improve lipid profiles and reduce cardiovascular risk by lowering triglycerides and LDL cholesterol.
GLP-1 Medications: A New Frontier for Joint Pain Relief
GLP-1 drugs like semaglutide and tirzepatide offer significant weight loss, which directly reduces mechanical stress and inflammation linked to
GLP-1 Agonists: Revolutionizing Metabolic Syndrome Treatment
Discover how GLP-1 receptor agonists transform metabolic syndrome management by targeting obesity, diabetes, hypertension, and dyslipidemia simultaneously.
GLP-1 Agonists: A New Era for Fatty Liver Disease?
Uncover the profound impact of GLP-1 receptor agonists on Non-Alcoholic Fatty Liver Disease (NAFLD) and its severe form, NASH, as a transformative
GLP-1 Medications: A New Frontier for Pre-Diabetes Prevention
GLP-1 drugs like Wegovy and Zepbound significantly reduce the risk of progressing to type 2 diabetes by promoting weight loss and improving metabolic health.
Fiber for GI Regularity on GLP-1s: Best Sources & Supplements
Managing constipation on GLP-1 medications like Wegovy and Zepbound requires strategic fiber intake. Learn the best food sources and supplements, backed by
GLP-1s and Sleep Apnea: A New Frontier in Treatment?
GLP-1 weight loss medications are showing promise in reducing obstructive sleep apnea severity, potentially changing management for patients with obesity
GLP-1 Medications Target Insulin Resistance for PCOS Weight Loss
GLP-1 drugs like semaglutide significantly reduce weight in PCOS patients by improving insulin resistance, a core driver of the condition. Discover how they
GLP-1 Meal Prep: Optimize Nutrition with Smaller Portions
Discover practical, high-protein meal prep ideas for managing reduced appetite on GLP-1 medications. Learn how to maximize nutrient density in smaller
GLP-1 for Type 2 Diabetes: Beyond Blood Sugar Control
GLP-1 medications for Type 2 Diabetes offer profound benefits beyond glucose management, protecting the heart, kidneys, and liver in patients.
Semaglutide's Heart Protection: Understanding SELECT Trial Results
The SELECT trial revealed semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with overweight/obesity and CVD, leading to FDA
GLP-1 Success: Measuring More Than Weight
Unlock a holistic view of GLP-1 progress. Go beyond the scale to track body composition, metabolic health, and non-scale victories for sustainable well-being.
Coffee and GLP-1s: Managing GI Symptoms and Absorption
Discover how coffee and caffeine interact with GLP-1 medications, potentially affecting GI symptoms and Rybelsus absorption. Learn tips for consumption.
GLP-1s & Pregnancy: Safety and Planning
For women on GLP-1s considering pregnancy: understand fertility impacts, crucial washout periods before conception, and current safety information
Intermittent Fasting with GLP-1s: Help or Harm to Results?
GLP-1 medications deliver significant weight loss. But does combining them with intermittent fasting enhance results or pose risks? Data shows caution.
Managing Social Eating on GLP-1s: Restaurants & Holidays
GLP-1s change how we eat, but social dining endures. Learn strategies for restaurants, holiday meals, and social pressure while on weight loss medication.
GLP-1 Medications: Unpacking Their Impact on Sleep Quality
GLP-1 medications primarily improve sleep quality by treating obesity-related conditions like sleep apnea, yet some report direct sleep changes.
Optimizing Nutrition While on GLP-1 Medications
Navigate your GLP-1 journey with smart food choices. Learn how to manage side effects and support wellness through an optimized diet.
Optimal Exercise on GLP-1: Maximize Fat Loss, Preserve Muscle
Master science-backed exercise strategies for GLP-1 users. Maximize fat loss, protect lean muscle, and boost metabolic health with tailored strength and
Alcohol and GLP-1s: Navigating Safety, Tolerance, and Weight Loss
Understand the complex interplay between alcohol consumption and GLP-1 medications, covering safety, altered tolerance, and impact on weight loss goals.
GLP-1s and Hydration: Why Water Intake Matters More
GLP-1 medications increase dehydration risk through reduced food intake and GI side effects. Learn why proactive hydration is critical for mitigating
Mastering Meal Timing & Portions on GLP-1 Medications
Strategize meal timing around GLP-1 injection day and learn to optimize small, nutrient-dense portions for effective weight loss and side effect management
Strength Training on GLP-1: Preserving Lean Muscle Mass
GLP-1 medications drive significant weight loss, but often at the cost of lean muscle. Learn evidence-based resistance training programs and nutrition
Optimizing Nutrient Intake on GLP-1 Medications
GLP-1 medications lead to significant weight loss, but often reduce food intake, risking nutrient deficiencies. Prioritize key vitamins, minerals, and
Navigating GLP-1s: Foods to Avoid for Better Comfort & Progress
Understand which foods can worsen GLP-1 side effects like nausea and slow weight loss. Learn evidence-based dietary strategies for improved comfort and
Protein Needs on GLP-1s: Fueling Weight Loss, Preserving Muscle
GLP-1 medications reduce appetite, leading to significant weight loss. Learn how to meet your increased protein needs (1.2-1.6 g/kg) to protect muscle mass
GLP-1s and Hypoglycemia: Low Risk for Non-Diabetics
GLP-1 medications rarely cause low blood sugar in non-diabetics using them for weight loss, but understanding the mechanisms and rare risk factors is
GLP-1s: What 5+ Year Safety Data Reveals About Sustained Use
Explore the long-term safety profile of GLP-1 medications, examining over five years of data on cardiovascular health, rare risks, and common side effects.
Mounjaro Cost: Maximizing Savings with Lilly's Savings Card
Unlock Mounjaro savings. Learn how Lilly's Savings Card can reduce monthly costs to $25 for eligible patients with commercial insurance, covering up to 13
GLP-1 Medications and Fatigue: Understanding and Managing Low Energy
Experiencing fatigue on GLP-1 medications like Wegovy or Zepbound? Learn why these drugs can cause low energy, focusing on caloric deficit, nutrient
GLP-1s and Alcohol: What Patients Report, What Research Reveals
Patients on GLP-1 medications often report reduced desire for alcohol. Research indicates these drugs can cut intake by 7.1 units weekly and impact AUD.
Managing GLP-1 Injection Site Reactions: Redness and Lumps
Injection site reactions are common with GLP-1s. Learn to differentiate mild redness and lumps from concerning signs, and best practices for site rotation.
Tirzepatide and Sulfur Burps: Understanding and Relief
Why do Mounjaro and Zepbound cause sulfur burps? This article explores the causes, including slowed gastric emptying, and offers evidence-based strategies
GLP-1s and Kidney Function: Protection vs. Dehydration Risks
GLP-1 medications offer significant renal protection for patients with type 2 diabetes and CKD, but understanding dehydration risks is crucial for safe use.
GLP-1s and Hair Loss: Rapid Weight Loss, Not the Drug, Is the Culprit
Investigate the link between GLP-1 medications like Wegovy and Zepbound and hair loss. Data suggests rapid weight loss, not the drug itself, is the primary
Kaiser Permanente GLP-1 Coverage 2026: A Deep Dive
Understanding Kaiser Permanente's GLP-1 coverage in 2026, including formulary medications, prior authorization, out-of-pocket costs, and appeals.
Noom Med vs. Hims: A Head-to-Head for GLP-1 Weight Loss
Compare Noom Med and Hims GLP-1 weight loss programs side-by-side. Analyze medication options, costs, physician support, and coaching to choose the right
Ozempic Face: Understanding and Treating Rapid Facial Volume Loss
Ozempic Face, a consequence of rapid GLP-1 weight loss, involves facial volume loss due to reduced fat and collagen. Explore causes and treatments like
ShedrX Review 2026: Tirzepatide Cost, Pricing, and How It Compares
Explore ShedrX's 2026 tirzepatide pricing, what's included, and physician access. We compare ShedrX to Remedy Meds and Henry Meds for GLP-1 weight loss.
Best Telehealth Weight Loss Programs 2026: GLP-1 Providers Ranked
GLP-1 Source ranks leading telehealth programs like Ro, Noom Med, Hims, and Found for weight loss in 2026. Compare costs, meds, and support.
GLP-1 Medications and Sleep Apnea: Evidence for New Treatment
GLP-1s, especially tirzepatide, are reshaping obstructive sleep apnea (OSA) treatment. Clinical evidence and FDA approval show significant symptom reduction
IVim Health Review 2026: GLP-1 Program Costs and Experience
An in-depth review of IVim Health's telehealth GLP-1 weight loss program for 2026, analyzing costs, compounded medication options, patient support, and how
Liraglutide Cost 2026: Brand vs. Generic Pricing Guide
Explore liraglutide (Saxenda) costs in 2026, including brand list prices, generic availability, and compounding options. Compare against newer GLP-1s for an
Molina Healthcare GLP-1 Coverage for Weight Loss in 2026
Molina Healthcare's 2026 GLP-1 coverage for weight loss varies by state Medicaid program. Learn formulary status, prior authorization, and alternatives.
Push Health Review 2026: Cost, How It Works, and GLP-1 Access
Review Push Health for GLP-1 prescriptions in 2026. Explore costs, platform functionality, medication access, and compare it to dedicated weight management
FDA's GLP-1 Compounding Policy: Rules & Shortage Resolution
Understand the FDA's strict policies on compounded GLP-1s, including the end of tirzepatide and semaglutide shortages, and what these changes mean for
FDA GLP-1 Compounding Policy: Tirzepatide Shortage Rules
The FDA issued major GLP-1 compounding policy updates in 2024 and 2025, covering tirzepatide shortage wind-down and semaglutide rules. What it means for
GLP-1 Agonists and Heart Health: Which Drugs Offer Cardioprotection?
Discover which GLP-1 agonists like semaglutide, liraglutide, and dulaglutide have proven cardiovascular benefits for patients with and without type 2
Managing Semaglutide GI Side Effects: Practical Strategies
Semaglutide's gastrointestinal side effects like constipation, diarrhea, and bloating are common. Learn evidence-based strategies to manage these issues
Preserving Muscle on GLP-1s: Your Guide to Lean Mass
GLP-1 medications are highly effective for weight loss, but often lead to muscle loss. Discover evidence-based strategies, including resistance training and
GLP-1s and Gallstones: Understanding Your Gallbladder Risk
Rapid weight loss from GLP-1 medications like Wegovy and Zepbound can increase gallstone risk. Learn why and how to recognize symptoms.
GLP-1s and Pancreatitis: Separating Fact from Fear
Explore the evidence behind GLP-1 weight loss medications and pancreatitis risk. Studies show a low but documented risk, often not increased over placebo in
GLP-1s and Thyroid Cancer: Deconstructing the Boxed Warning
Understand the FDA's boxed warning for GLP-1 medications and medullary thyroid carcinoma. Is there a real link to common thyroid cancers? Data explored.
Brand vs. Compounded Semaglutide: Safety, Efficacy, and Risks
Explore the crucial differences between FDA-approved semaglutide (Wegovy, Ozempic) and compounded versions, examining safety, efficacy, and regulatory risks.
GLP-1 Medication Half-Lives Compared: Why Dosing Frequency Matters
Semaglutide lasts 7 days, tirzepatide 5 days, dulaglutide 4.7 days. How drug half-life determines your injection schedule and affects weight loss results.
Missing a GLP-1 Dose: What Actually Happens and When to Worry
Clinical guidance on missed weekly and daily GLP-1 doses. FDA protocols show semaglutide has a 5-day window, liraglutide 12 hours.
Oral vs Injectable GLP-1s: The Convenience-Efficacy Trade-off
Injectable semaglutide delivers 14.9% weight loss vs 9.6% for oral in trials. Here's what the data reveals about pills versus shots for GLP-1 therapy.
How to Inject Semaglutide: Step-by-Step Guide
Proper injection technique matters. Learn where to inject semaglutide, how to rotate sites correctly, and avoid the mistakes that affect absorption.
How to Inject Tirzepatide: Mounjaro and Zepbound Pen Instructions
Step-by-step injection guide for tirzepatide auto-injector pens. Proper technique, rotation sites, and troubleshooting for Mounjaro and Zepbound.
Storing GLP-1 Medications: Temperature Rules and Travel Tips
Refrigeration requirements for Ozempic, Wegovy, and other GLP-1s. What happens if left out, how long they last at room temperature, and travel strategies.
Survodutide: The Dual Agonist Targeting NASH and Obesity
Survodutide combines GLP-1 and glucagon to tackle liver disease and weight loss. Phase 2 data shows 18.7% weight reduction and breakthrough FDA status
Switching from Ozempic to Mounjaro: What to Know
Mounjaro delivers 21.1% weight loss versus Ozempic's 14.9% in head-to-head trials. Here's the evidence-based guide to transitioning medications.
Switching from Wegovy to Zepbound: Dosing Crossover Guide
Evidence-based protocol for transitioning between semaglutide and tirzepatide, including dose mapping, titration schedules, and managing the crossover
CagriSema: Why Novo's Dual-Pathway Drug Hits 22.7% Weight Loss
Novo Nordisk's CagriSema combines semaglutide with amylin analog cagrilintide, targeting GLP-1 and amylin pathways. Phase III data shows 22.7% weight loss.
Orforglipron: The Oral GLP-1 That Could End Weekly Injections
Lilly's orforglipron delivered 12% weight loss in Phase 3 trials and beat Novo's Rybelsus head-to-head. Why this daily pill could reshape GLP-1 treatment.
Pemvidutide: The GLP-1/Glucagon Dual Agonist Targeting Liver Fat
Altimmune's pemvidutide combines GLP-1 and glucagon receptor activation to reduce liver fat by up to 55% while delivering weight loss in Phase 2 trials.
How Tirzepatide Works: Dual GIP/GLP-1 Action Explained
Tirzepatide targets two hormone receptors instead of one. The SURMOUNT-1 trial showed 20.9% weight loss—nearly double semaglutide's results.
Liraglutide (Saxenda): The First GLP-1 for Weight Loss
Liraglutide produced 4.5% average weight loss in FDA trials—modest compared to newer GLP-1s but now available as a lower-cost generic option.
Rybelsus: The Oral Semaglutide That Trails Injectable Versions
Rybelsus delivers semaglutide in pill form but produces 8-10 lbs weight loss vs 15% body weight for injections. How the oral option stacks up.
Retatrutide: The Triple Agonist Showing 28.7% Weight Loss
Lilly's retatrutide targets GLP-1, GIP, and glucagon receptors. Phase 3 data shows 28.7% weight loss at 68 weeks—but seven trials remain before approval.
Victoza vs Saxenda: Same Molecule, Different Doses
Liraglutide works for diabetes at 1.8mg (Victoza) and weight loss at 3.0mg (Saxenda). Same drug, different FDA approvals—here's what the data shows.
Mounjaro for Weight Loss: Off-Label Use Explained
Doctors prescribed Mounjaro off-label for weight loss from 2022-2023, producing 20.9% weight loss before FDA approved Zepbound. Here's why and what happened.
Ozempic vs Wegovy: Same Drug, Different FDA Approvals
Both contain semaglutide, but Wegovy delivers 2.4mg weekly for weight loss while Ozempic maxes at 2mg for diabetes. Here's why the same molecule has two
Semaglutide Dosing Schedule: Week-by-Week Titration Guide
The standard semaglutide titration starts at 0.25mg weekly for 4 weeks, escalating to 2.4mg over 16-20 weeks. Here's what happens at each dose.
Tirzepatide vs Semaglutide: Which GLP-1 Works Better
Head-to-head trial data shows tirzepatide produced 20.9% weight loss vs 14.7% for semaglutide at 72 weeks. Cost, side effects, and efficacy compared.
Zepbound Dosing Guide: Titration and Maintenance
Step-by-step Zepbound dosing from 2.5mg to 15mg. FDA-approved titration schedule, timing strategies, and what clinical trials reveal about dose escalation.
How Semaglutide Works for Weight Loss: The Science Explained
Semaglutide mimics GLP-1 to reduce appetite through brain signaling and slow digestion. Here's the mechanism behind 15-20% weight loss in clinical trials.
GLP-1 Side Effects: What to Expect and How to Cope
A practical guide to GLP-1 medication side effects with frequency data from clinical trials, management tips, and when to call your doctor.
How to Choose a GLP-1 Telehealth Provider
Seven things to evaluate before signing up for a GLP-1 program. Plus red flags to avoid, questions to ask, and how we rank providers.
Semaglutide vs Tirzepatide: Which Works Better?
Head-to-head comparison of semaglutide and tirzepatide for weight loss. We cover clinical trial data, side effects, pricing, and which one fits you.
Oscar Insurance GLP-1 Coverage 2026: What to Know
Navigating Oscar Insurance GLP-1 coverage for weight loss in 2026. Learn about Ozempic, Wegovy, and Mounjaro access, prior authorization, and appeal
What Are GLP-1 Medications? A Beginner's Guide
Learn what GLP-1 receptor agonist medications are, how they work for weight loss, common side effects, and how to decide if they're right for you.